600873 梅花生物
按盤價 
10.000 +0.030 (+0.301%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.720 | 21.220 | 19.072 | 22.985 | 36.432 |
| 總資產報酬率 ROA (%) | 0.455 | 13.196 | 11.670 | 13.352 | 19.381 |
| 投入資產回報率 ROIC (%) | 0.511 | 14.998 | 13.284 | 15.318 | 22.413 | 邊際利潤分析 |
| 銷售毛利率 (%) | 9.529 | 18.998 | 20.075 | 19.681 | 25.133 |
| 營業利潤率 (%) | 2.327 | 12.017 | 13.927 | 13.737 | 18.471 |
| 息稅前利潤/營業總收入 (%) | 3.005 | 15.423 | 12.893 | 13.291 | 18.744 |
| 淨利潤/營業總收入 (%) | 1.970 | 13.552 | 10.931 | 11.459 | 15.772 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 66.843 | 69.841 | 95.737 | 96.746 | 96.008 |
| 價值變動淨收益/利潤總額(%) | 10.309 | 2.431 | 1.344 | -0.819 | 1.107 |
| 營業外收支淨額/利潤總額(%) | 9.748 | 22.003 | -4.234 | -2.424 | -0.143 | 償債能力分析 |
| 流動比率 (X) | 1.387 | 1.334 | 1.196 | 1.456 | 1.486 |
| 速動比率 (X) | 0.737 | 0.918 | 0.830 | 1.009 | 0.876 |
| 資產負債率 (%) | 36.781 | 36.921 | 38.785 | 38.840 | 44.813 |
| 帶息債務/全部投入資本 (%) | 27.642 | 26.894 | 27.983 | 28.287 | 33.076 |
| 股東權益/帶息債務 (%) | 255.699 | 265.552 | 249.687 | 245.454 | 193.365 |
| 股東權益/負債合計 (%) | 171.882 | 170.849 | 157.830 | 157.469 | 123.151 |
| 利息保障倍數 (X) | 7.041 | 932.365 | -27.563 | -110.382 | 62.433 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 8.832 | 8.664 | 8.825 | 6.367 | 4.004 |
| 存貨周轉天數 (天) | 63.315 | 52.725 | 50.710 | 56.437 | 60.763 |
| 備註： | 即時報價更新時間為 23/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
